Creative Medical Technology Holdings, Inc. Additional Paid in Capital, Common Stock
Creative Medical Technology Holdings, Inc. (CELZ) had Additional Paid in Capital, Common Stock of $18.55 million as of 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2020-05-15
- 2020-03-31: Additional Paid in Capital, Common Stock $18.55M.
- 2019-12-31: Additional Paid in Capital, Common Stock $17.47M.
- 2019-09-30: Additional Paid in Capital, Common Stock $14.70M.
- 2019-06-30: Additional Paid in Capital, Common Stock $14.14M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2020-03-31 | $18.55M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $17.47M 10-Q · filed 2020-05-15 | |
| 2019-09-30 | $14.70M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $14.14M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $13.26M 10-Q · filed 2019-05-20 | |
| 2018-12-31 | $13.08M 10-K · filed 2020-04-06 | $12.18M 10-K · filed 2019-04-01 |
| 2018-09-30 | $10.87M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $6.17M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.68M 10-Q · filed 2018-08-03 | |
| 2017-12-31 | $1.07M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $769.08K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $767.39K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $604.23K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $503.77K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $135.64K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $6.20K 10-Q · filed 2016-08-19 | |
| 2015-12-31 | $17.99K 10-K · filed 2017-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |